BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38538929)

  • 1. Molecular insights and the role of 18F-FDG-PET/CT in the diagnosis of spinal gliomas.
    Nagashima Y; Nishimura Y; Eguchi K; Yamaguchi J; Haimoto S; Ohka F; Motomura K; Abe T; Matsuo M; Tsukamoto E; Hara M; Saito R
    Acta Neurochir (Wien); 2024 Mar; 166(1):154. PubMed ID: 38538929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
    Wang K; Zhao X; Chen Q; Fan D; Qiao Z; Lin S; Jiang T; Dai J; Ai L
    Medicine (Baltimore); 2017 Aug; 96(32):e7756. PubMed ID: 28796066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effectiveness of Preoperative 18F-FDG PET/CT in Predicting Pathological Tumor Grade in Patients with Pseudomyxoma Peritonei Originating from Appendix: A Retrospective Cohort Study.
    Aso K; Gohda Y; Hotta M; Minamimoto R; Shimizu Y; Uemura Y; Yano H
    Ann Surg Oncol; 2024 Mar; 31(3):1990-1995. PubMed ID: 38082170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Combined Scoring Method Based on 18F-FDG PET/CT for Distinguishing Spinal Infection From Malignancy.
    Chen J; Xue L; Li X; Xiong W
    Spine (Phila Pa 1976); 2023 Feb; 48(4):270-277. PubMed ID: 36692156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection.
    Mitra A; Pencharz D; Davis M; Wagner T
    Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative analysis of spinal intramedullary lesions using PET/CT.
    Naito K; Yamagata T; Arima H; Abe J; Tsuyuguchi N; Ohata K; Takami T
    J Neurosurg Spine; 2015 Nov; 23(5):613-619. PubMed ID: 26230418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between
    Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
    Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
    Zhang C; Liang Z; Liu W; Zeng X; Mo Y
    BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine.
    Tomura N; Ito Y; Matsuoka H; Saginoya T; Numazawa SI; Mizuno Y; Watanabe K
    AJNR Am J Neuroradiol; 2013; 34(6):1278-83. PubMed ID: 23275592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer.
    Yu L; Huang S; Wu S; Yue J; Yin L; Lin Z
    Medicine (Baltimore); 2023 Jan; 102(2):e32331. PubMed ID: 36637950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A; Brennum J; Broholm H; Law I
    J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT using
    Liu D; Cheng G; Ma X; Wang S; Zhao X; Zhang W; Yang W; Wang J
    J Neuroimaging; 2021 Jul; 31(4):733-742. PubMed ID: 34021667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.